Skip to main content
. 2022 Apr 2;20:16. doi: 10.1186/s12962-022-00352-5

Table 2.

Cost-effectiveness analysis of base-case for patients with ESCC

Treatment interventions Total cost per patient (US $) QALY LYG ICER (US$/QALY) ICER (US$/LYG)
Stage I
 EMR 4485.6 3.045 4.363 Reference Reference
 Esophagectomy 5582.6 3.033 4.353 Dominated Dominated
 EMR followed by ablation 4753.9 2.884 4.136 Dominated Dominated
Stage II and III
 CRT 4738.9 2.143 2.821 Reference Reference
 CRT followed by surgery 6707 3.048 4.013 2172.8 1650.9
 Esophagectomy 7622.8 2.664 3.509 Dominated Dominated